Evidence map›Paper›PMID 23868003›Full record

ArticleBritish journal of cancer2013

International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer.

S Wheelwright, A-S Darlington, D Fitzsimmons, P Fayers, J I Arraras, F Bonnetain, E Brain, A Bredart, W-C Chie, J Giesinger and 9 more

3 registry-linked trialsAbstract readValidation Study
In one paragraph

Article in British journal of cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03343210 naterminatednot on this mapstarted 2018, after this paper: background citation

Quality of Life and Cancers in Nursing Homes

TypeinterventionalSponsorUniversity Hospital, CaenRan2018 to 2020Enrolled73ConditionsQuality of Life, Cancer, Nurse's RoleArmsquality of life and pain measurement .
NCT03673332 phase4terminatednot on this mapstarted 2019, after this paper: background citation

Elderly Cancer PatIents Treated for Advanced or Metastatic Melanoma or NSCLC, Safety and qualiTy of Life Under immunOtheraPies: a Phase IV Trial

TypeinterventionalSponsorInstitut Paoli-CalmettesRan2019 to 2024Enrolled40ConditionsAdvanced or Metastatic Melanoma, Advanced or Metastatic NSCLCArmsimmune-checkpoint inhibitors therapies
NCT07460726 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

A Single Arm Prospective Study to Investigate the Impact of Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) on Sexual Dysfunction in Unfavorable Intermediate Risk Prostate Cancer

Typeobservational_patient_registrySponsorCancerCare ManitobaRan2026 to 2029Enrolled130ConditionsProstate Cancer (Adenocarcinoma), Erectile Abnormalities, Sexual Dysfunction MaleArmsSBRT combined with ADT
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016
    Trial
  10. Image-guided high-dose-rate brachytherapy after short-course external beam radiotherapy for elderly/frail rectal cancer patients.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Quality of life in very long-term (including > 20 years' follow-up) early-stage breast cancer survivors from Spain.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  18. Article
  19. Clinical Frailty Scale versus Geriatric-8 in predicting quality of life among older adults receiving curative cancer treatment.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

S WheelwrightCancer Sciences, University of Southampton, Southampton SO16 6YD, UK. s.j.wheelwright@soton.ac.uk
A-S Darlington
D Fitzsimmons
P Fayers
J I Arraras
F Bonnetain
E Brain
A Bredart
W-C Chie
J Giesinger
E Hammerlid
S J O'Connor
S Oerlemans
A Pallis
M Reed
N Singhal
V Vassiliou
T Young
C Johnson

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOlder people represent the majority of cancer patients but their specific needs are often ignored in the development of health-related quality of life (HRQOL) instruments. The European Organisation for Research and Treatment of Cancer (EORTC) QLQ-ELD15 was developed to supplement the EORTC's core questionnaire, the QLQ-C30, for measuring HRQOL in patients aged >70 years in oncology studies.

methodsPatients (n=518) from 10 countries completed the QLQ-C30, QLQ-ELD15 and a debriefing interview. Eighty two clinically stable patients repeated the questionnaires 1 week later (test-retest analysis) and 107 others, with an expected change in clinical status, repeated the questionnaires 3 months later (response to change analysis, RCA).

resultsInformation from the debriefing interview, factor analysis and item response theory analysis resulted in the removal of one item (QLQ-ELD15QLQ-ELD14) and revision of the proposed scale structure to five scales (mobility, worries about others, future worries, maintaining purpose and illness burden) and two single items (joint stiffness and family support). Convergent validity was good. In known-group comparisons, the QLQ-ELD14 differentiated between patients with different disease stage, treatment intention, number of comorbidities, performance status and geriatric screening scores. Test-retest and RCA analyses were equivocal.

conclusionThe QLQ-ELD14 is a validated HRQOL questionnaire for cancer patients aged 70 years. Changes in elderly patients' self-reported HRQOL may be related to both cancer evolution and non-clinical events.

Indexed as

Health StatusActivities of Daily LivingAgedAged, 80 and overCohort StudiesFemaleGeriatric AssessmentHumansMaleNeoplasmsProspective StudiesPsychometricsQuality of LifeReproducibility of ResultsSurveys and Questionnaires

Identifiers

PMID23868003
PMCPMC3749575

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.